Selleck Chemicals - Model A2378 -Rinucumab (Anti-PDGFRB / CD140b)

Rinucumab (Anti-PDGFRB / CD140b) is an anti-platelet-derived growth factor receptor beta (anti-PDGFR-beta) monoclonal antibody and has a potential to study neovascular age-related macular degeneration. MW: 145.5 kD.